Search
for
Sort by
Research 30 of 1000+
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- New treatment modalities of alopecia areata
- The role of janus kinases in the treatment of autoimmune skin diseases
- What’s new in the treatment of hair loss?
- Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US
- Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany
- Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
- The Frontal Fibrosing Alopecia Treatment Dilemma
- New Treatment Options for Alopecia Areata
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- Lipid nanocarriers as innovative strategies for hair regrowth
- The Role of Janus Kinase Inhibitors in Dermatology
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- When hair dig into the brain, JAKi , may help!
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- The importance and use of stem cells in dermatology